Cryolife Inc. News Releases http://investors.cryolife.com/ Cryolife Inc. News Releases en CryoLife Reports First Quarter 2019 Financial Results http://investors.cryolife.com/news-releases/news-release-details/cryolife-reports-first-quarter-2019-financial-results ATLANTA , April 30, 2019 /PRNewswire/ -- First Quarter and Recent Business Highlights: Total revenues were $67.5 million in the first quarter of 2019, reflecting year over year growth of 9% and an 11% increase on a non-GAAP constant currency basis, both compared to the first quarter of 2018 On-X ® Tue, 30 Apr 2019 16:05:00 -0400 Cryolife Inc. News Releases 18341 CryoLife Announces Release Date and Teleconference Call Details for 2019 First Quarter Financial Results http://investors.cryolife.com/news-releases/news-release-details/cryolife-announces-release-date-and-teleconference-call-64 ATLANTA , April 17, 2019 /PRNewswire/ --  CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2019 first quarter financial results will be released on Tuesday, April 30, 2019 after the market closes.  On that day, the Company Wed, 17 Apr 2019 17:05:00 -0400 Cryolife Inc. News Releases 18326 CryoLife to Present at 18th Annual Needham Healthcare Conference http://investors.cryolife.com/news-releases/news-release-details/cryolife-present-18th-annual-needham-healthcare-conference ATLANTA , April 3, 2019 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming 18 th Annual Needham Healthcare Conference on Wednesday, April 10, 2019 at the Westin Grand Central Wed, 03 Apr 2019 08:30:00 -0400 Cryolife Inc. News Releases 18316 CryoLife to Present at Cowen and Company 39th Annual Health Care Conference http://investors.cryolife.com/news-releases/news-release-details/cryolife-present-cowen-and-company-39th-annual-health-care ATLANTA , March 5, 2019 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming Cowen and Company 39 th Annual Health Care Conference on Monday, March 11, 2019 at The Boston Tue, 05 Mar 2019 17:00:00 -0500 Cryolife Inc. News Releases 18161 CryoLife Reports Fourth Quarter and Full Year 2018 Financial Results http://investors.cryolife.com/news-releases/news-release-details/cryolife-reports-fourth-quarter-and-full-year-2018-financial ATLANTA , Feb. 13, 2019 /PRNewswire/ --   Fourth Quarter and Recent Business Highlights: Total revenues were $67.8 million in the fourth quarter of 2018, reflecting year over year growth of 28% and an 8% increase on a non-GAAP constant currency basis compared to the fourth quarter of 2017 On-X ® Wed, 13 Feb 2019 19:30:00 -0500 Cryolife Inc. News Releases 18011 CryoLife Announces Release Date and Teleconference Call Details for 2018 Fourth Quarter and Year-end Financial Results http://investors.cryolife.com/news-releases/news-release-details/cryolife-announces-release-date-and-teleconference-call-63 ATLANTA , Feb. 1, 2019 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2018 fourth quarter and year-end financial results will be released on Wednesday, February 13, 2019 after the market closes. Fri, 01 Feb 2019 17:00:00 -0500 Cryolife Inc. News Releases 17991 CryoLife Reports Third Quarter 2018 Results http://investors.cryolife.com/news-releases/news-release-details/cryolife-reports-third-quarter-2018-results ATLANTA , Oct. 31, 2018 /PRNewswire/ --   CryoLife, Inc. (NYSE: CRY) , a leading cardiac and vascular surgery company focused on aortic disease, announced today its financial results for the third quarter ended September 30, 2018 . Third Quarter and Recent Business Highlights: Total revenues Wed, 31 Oct 2018 17:04:00 -0400 Cryolife Inc. News Releases 17961 CryoLife Reports Preliminary Financial Results for Third Quarter 2018 in Anticipation of Discussions with Senior Lenders Regarding Repricing Senior Credit Facility http://investors.cryolife.com/news-releases/news-release-details/cryolife-reports-preliminary-financial-results-third-quarter Announces Release Date and Teleconference Call Details for 2018 Third Quarter Financial Results ATLANTA , Oct. 15, 2018 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, in anticipation of discussions with its senior lenders Mon, 15 Oct 2018 17:00:00 -0400 Cryolife Inc. News Releases 17941 CryoLife to Present at Deutsche Bank 26th Annual Leveraged Finance Conference http://investors.cryolife.com/news-releases/news-release-details/cryolife-present-deutsche-bank-26th-annual-leveraged-finance ATLANTA , Sept. 18, 2018 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming Deutsche Bank 26 th Annual Leveraged Finance Conference on Tuesday, October 2, 2018 at The Tue, 18 Sep 2018 17:00:00 -0400 Cryolife Inc. News Releases 17911 CryoLife Reports Second Quarter 2018 Results http://investors.cryolife.com/news-releases/news-release-details/cryolife-reports-second-quarter-2018-results ATLANTA , Aug. 6, 2018 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY) , a leading cardiac and vascular surgery company focused on aortic disease, announced today its financial results for the second quarter ended June 30 , 2018.  Second Quarter and Recent Business Highlights: Total revenues increased Mon, 06 Aug 2018 17:30:00 -0400 Cryolife Inc. News Releases 17771